Pharmaceutical M&A came back with a bang during October, after a quiet September. Merck & Co (NYSE: MRK) and AbbVie (NYSE: ...

AstraZeneca showcased positive early data on three experimental weight-loss drugs at ObesityWeek, highlighting its oral GLP-1 ...

European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo ...

US biopharma Vertex Pharmaceuticals was trading nearly 2% higher during pre-market trading on Tuesday. This followed Vertex’s ...

Spanish drugmaker PharmaMar Group today said it has received a payment of $10 million from Janssen Products, a Johnson & ...

French biotech Transgene today revealed it has entered into a license agreement with Germany-based contract development and ...

California, USA-based biotech Nektar Therapeutics’ (Nasdaq: NKTR) shares closed up more than 8% at $1.33 yesterday after it ...

US neuroscience-focused biopharma Neurocrine Biosciences presented new data from more than 300 patients diagnosed with tardive dyskinesia and treated with Ingrezza (valbenazine) capsules at the 2024 ...

Privately-held German drugmaker Boehringer Ingelheim and researchers from the Stanley Center for Psychiatric Research at the ...

The US Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for donidalorsen, an ...

Disc Medicine today announced a successful End of Phase 2 with the US Food and Drug Administration (FDA) supporting the ...

The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. It shows how important the ...